Company Overview

PRIME exits® and American HealthCare Capital are pleased to exclusively represent a Long Term Care Pharmacy for sale in the Midwest. Founded more than a decade ago, the pharmacy has built deep expertise in managing the specialized medication needs of behavioral and mental health populations, which now represent approximately 80% of all prescriptions filled.

The pharmacy provides comprehensive LTC services to mental health facilities, assisted living facilities and group homes. Services include medication dispensing, adherence-focused packaging, clinical coordination, and reliable delivery solutions tailored for facilities that require consistent, high-touch pharmacy support.

Financial Overview

The company has experienced strong and accelerating growth driven by its focus on mental health long-term care pharmacy services. Revenues increased by 83% from 2022 to 2023 and by 36% annually in both 2024 and 2025. The business is projected to end 2025 with approximately $15 million in revenue and $1.5 million in EBITDA.

The pharmacy currently serves more than 1,500 patients. New contracts with multiple mental health facilities are expected to generate more than $6 million in new annual revenue and approximately $750,000 in added net profit. As a result, projected 2026 revenue is expected to exceed $21 million, with net profit of more than $2.3 million, reflecting continued scalability and strong market positioning.

Staff Overview

All staff members are expected to remain on board under new ownership. Many employees have long tenure with the company, contributing to continuity, operational consistency, and low turnover. The owner is available to support a buyer during a transition period to ensure operational continuity and a smooth handoff.

Asking Price

The seller is seeking $11,350,000, plus inventory for the business. The real estate may be purchased for an additional $1.4 million.